相关实验视频

Updated: Jun 2, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

脑髓母细胞瘤的高细胞可塑性状态局部复发和远程传播

Hailong Liu¹, Jing Zhang², Ziwei Wang³

¹Department of Radiotherapy, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Beijing Neurosurgical Institute, Beijing 100070, China; China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China; Chinese Institute for Medical Research, Beijing 100069, China.

Cell reports. Medicine

|January 14, 2025

概括

研究人员确定了一个高细胞可塑性 (HCP) 亚群,导致脑髓母细胞瘤 (MB) 复发. 抑制像PTPRZ1这样的HCP标记物在临床前模型中抑制了瘤进展,为这种儿科脑瘤提供了新的治疗策略.

科学领域:

神经瘤学神经瘤学
基因组学就是基因组学.
癌症生物学癌症生物学

背景情况:

骨髓母细胞瘤 (MB) 是一种异质的儿科脑瘤,具有具有挑战性的复发和扩散.
了解细胞多样性和遗传改变对于有效治疗至关重要.

研究的目的:

描述复发性脑髓母细胞瘤的细胞多样性和遗传特征.
确定瘤复发和扩散的关键驱动因素.
探索脑髓母细胞瘤的潜在治疗点.

主要方法:

对单细胞/核RNA测序 (sc/snRNA-seq),snATAC-seq和空间转录组学的全面分析.
在MB进展过程中对染色体变化的评估.
临床前模型用于测试已识别的标记物的治疗抑制.

主要成果:

在SHH和Group_3 MB亚组中确定了不同的细胞群,在局部复发与传播方面有所不同.
局部复发丰富了循环瘤细胞;散布的病变显示出更多的差异化子集.
一个"高细胞可塑性" (HCP) 亚群出现,与增加的增殖,染色质可访问性和复发有关.
在Group_3传播中发现了特定的染色体变化 (chr7q增加,chr11损失).
在临床前模型中,抑制HCP标记物PTPRZ1抑制了MB进展.

结论:

研究结果揭示了关于细胞异质性,遗传进化和复发性脑髓母细胞瘤的生物动态的关键见解.
医疗保健专家子群代表了脑髓母细胞瘤的潜在治疗脆弱性.
针对PTPRZ1等与HPC相关的标记物显示出治疗儿科复发性脑瘤的前景.

关键词:

这就是PTPRZ1Z.细胞的可塑性细胞的可塑性脑髓母细胞瘤是什么意思复发和传播的情况.

更多相关视频

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...